标题
Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
作者
关键词
-
出版物
Cancers
Volume 9, Issue 12, Pages 52
出版商
MDPI AG
发表日期
2017-05-17
DOI
10.3390/cancers9050052
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinoma
- (2017) Jin Zhou et al. Nature Communications
- Epidermal Growth Factor Pathway Signaling in Drosophila Embryogenesis: Tools for Understanding Cancer
- (2017) Jay Lusk et al. Cancers
- Final STEPP results of prophylacatic versus reactive skin toxicity (ST) treatment (tx) for panitumumab (pmab)-related ST in patients (pts) with metastatic colorectal cancer (mCRC)
- (2017) E. P. Mitchell et al. JOURNAL OF CLINICAL ONCOLOGY
- Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial
- (2016) Keunchil Park et al. LANCET ONCOLOGY
- New structural and functional insight into the regulation of Ras
- (2016) Yoshihito Kano et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Tyrosine 370 phosphorylation of ATM positively regulates DNA damage response
- (2015) Hong-Jen Lee et al. CELL RESEARCH
- EGF stimulates the activation of EGF receptors and the selective activation of major signaling pathways during mitosis
- (2015) Ping Wee et al. CELLULAR SIGNALLING
- A phase 1 study of ABT-806 in subjects with advanced solid tumors
- (2015) James M. Cleary et al. INVESTIGATIONAL NEW DRUGS
- Dimerization drives EGFR endocytosis through two sets of compatible endocytic codes
- (2015) Q. Wang et al. JOURNAL OF CELL SCIENCE
- Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K
- (2015) Rupert Courtnay et al. MOLECULAR BIOLOGY REPORTS
- The genomic landscape of response to EGFR blockade in colorectal cancer
- (2015) Andrea Bertotti et al. NATURE
- The history and future of targeting cyclin-dependent kinases in cancer therapy
- (2015) Uzma Asghar et al. NATURE REVIEWS DRUG DISCOVERY
- Regulation of mTORC1 by PI3K signaling
- (2015) Christian C. Dibble et al. TRENDS IN CELL BIOLOGY
- Targeting Breast Cancer with CDK Inhibitors
- (2015) Erica L. Mayer Current Oncology Reports
- Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis
- (2015) Severa Bunda et al. Nature Communications
- NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition
- (2015) M. E. R. Garcia-Rendueles et al. Cancer Discovery
- EGF-dependent re-routing of vesicular recycling switches spontaneous phosphorylation suppression to EGFR signaling
- (2015) Martin Baumdick et al. eLife
- EGFR-mutated lung cancer: a paradigm of molecular oncology
- (2015) Oncotarget
- ExtendedRASmutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials
- (2014) M. J. Sorich et al. ANNALS OF ONCOLOGY
- FOXC1 is a Critical Mediator of EGFR Function in Human Basal-like Breast Cancer
- (2014) Yanli Jin et al. ANNALS OF SURGICAL ONCOLOGY
- A new tumour suppression mechanism by p27Kip1: EGFR down-regulation mediated by JNK/c-Jun pathway inhibition
- (2014) Yong Fang et al. BIOCHEMICAL JOURNAL
- Akt-dependent Activation of mTORC1 Complex Involves Phosphorylation of mTOR (Mammalian Target of Rapamycin) by IκB Kinase α (IKKα)
- (2014) Han C. Dan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Actively Targeted Cetuximab Conjugated γ-Poly(glutamic acid)-Docetaxel Nanomedicines for Epidermal Growth Factor Receptor Over Expressing Colon Cancer Cells
- (2014) S. Maya et al. Journal of Biomedical Nanotechnology
- Quantification and Kinetic Analysis of Grb2-EGFR Interaction on Micro-Patterned Surfaces for the Characterization of EGFR-Modulating Substances
- (2014) Peter Lanzerstorfer et al. PLoS One
- Opposing Functions of Akt Isoforms in Lung Tumor Initiation and Progression
- (2014) Nicolle M. Linnerth-Petrik et al. PLoS One
- Src promotes GTPase activity of Ras via tyrosine 32 phosphorylation
- (2014) S. Bunda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast Cancer
- (2014) J. J. Tao et al. Science Signaling
- Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer
- (2014) S. Misale et al. Science Translational Medicine
- Emerging concepts in the regulation of the EGF receptor and other receptor tyrosine kinases
- (2014) Nicholas F. Endres et al. TRENDS IN BIOCHEMICAL SCIENCES
- AG1478 inhibits the migration and invasion of cisplatin-resistant human lung adenocarcinoma cells via the cell cycle regulation by matrix metalloproteinase-9
- (2014) LI MA et al. Oncology Letters
- Gefitinib induces cytoplasmic translocation of the CDK inhibitor p27 and its binding to a cleaved intermediate of caspase 8 in non-small cell lung cancer cells
- (2014) Sun Hee Ahn et al. CELLULAR ONCOLOGY
- Complex Relationship between Ligand Binding and Dimerization in the Epidermal Growth Factor Receptor
- (2014) Nicholas J. Bessman et al. Cell Reports
- Targeting PI3K/Akt/mTOR Signaling in Cancer
- (2014) Camillo Porta et al. Frontiers in Oncology
- Combination of Antibody That Inhibits Ligand-Independent HER3 Dimerization and a p110 Inhibitor Potently Blocks PI3K Signaling and Growth of HER2+ Breast Cancers
- (2013) J. T. Garrett et al. CANCER RESEARCH
- Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer
- (2013) Kamal S. Saini et al. CANCER TREATMENT REVIEWS
- Distinct and specific roles of AKT1 and AKT2 in androgen-sensitive and androgen-independent prostate cancer cells
- (2013) Ariel E. Cariaga-Martinez et al. CELLULAR SIGNALLING
- Threshold-controlled ubiquitination of the EGFR directs receptor fate
- (2013) Sara Sigismund et al. EMBO JOURNAL
- Ocular adverse events of molecularly targeted agents approved in solid tumours: A systematic review
- (2013) Olivier Huillard et al. EUROPEAN JOURNAL OF CANCER
- The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered
- (2013) Hui K. Gan et al. FEBS Journal
- The molecular rationale of Src inhibition in colorectal carcinomas
- (2013) Antonios N. Gargalionis et al. INTERNATIONAL JOURNAL OF CANCER
- Cellular Functions Regulated by Phosphorylation of EGFR on Tyr845
- (2013) Ken-ichi Sato INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- 1133 P27KIP1 DOWN-REGULATES EGFR EXPRESSION VIA INHIBITION OF JNK/C-JUN TRANSACTIVATION: A NOVEL FUNCTION OF P27KIP1 IN TUMOR SUPPRESSION DEFICIENT IN METASTATIC BLADDER CANCER CELLS
- (2013) Yong Fang et al. JOURNAL OF UROLOGY
- The ErbB/HER family of protein-tyrosine kinases and cancer
- (2013) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Mechanism for activation of mutated epidermal growth factor receptors in lung cancer
- (2013) M. Red Brewer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combined targeting of MEK and PI3K/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo
- (2013) C. Posch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural, Biochemical, and Clinical Characterization of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations in Lung Cancer
- (2013) H. Yasuda et al. Science Translational Medicine
- EGF receptor trafficking: consequences for signaling and cancer
- (2013) Alejandra Tomas et al. TRENDS IN CELL BIOLOGY
- HER3 signalling is regulated through a multitude of redundant mechanisms in HER2-driven tumour cells
- (2012) Dhara N. Amin et al. BIOCHEMICAL JOURNAL
- Protein kinase C (PKC) isozyme-specific substrates and their design
- (2012) Jeong-Hun Kang et al. BIOTECHNOLOGY ADVANCES
- Gefitinib-Resistance Is Related to BIM Expression in Non-Small Cell Lung Cancer Cell Lines
- (2012) Heyan Li et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- MEK Inhibition Leads to PI3K/AKT Activation by Relieving a Negative Feedback on ERBB Receptors
- (2012) A. B. Turke et al. CANCER RESEARCH
- The Skp2-SCF E3 Ligase Regulates Akt Ubiquitination, Glycolysis, Herceptin Sensitivity, and Tumorigenesis
- (2012) Chia-Hsin Chan et al. CELL
- Oncogenic Mutations Counteract Intrinsic Disorder in the EGFR Kinase and Promote Receptor Dimerization
- (2012) Yibing Shan et al. CELL
- MYC on the Path to Cancer
- (2012) Chi V. Dang CELL
- Suppression of survival signalling pathways by the phosphatase PHLPP
- (2012) Audrey K. O’Neill et al. FEBS Journal
- Lipid metabolism in cancer
- (2012) Claudio R. Santos et al. FEBS Journal
- Regulation of the Src Family Kinases by Csk
- (2012) Masato Okada International Journal of Biological Sciences
- Mechanisms for Kinase-mediated Dimerization of the Epidermal Growth Factor Receptor
- (2012) Chafen Lu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MEK inhibitors reverse resistance in epidermal growth factor receptor mutation lung cancer cells with acquired resistance to gefitinib
- (2012) Ming-Hung Huang et al. Molecular Oncology
- Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
- (2012) Zhenfeng Zhang et al. NATURE GENETICS
- PI3K signalling: the path to discovery and understanding
- (2012) Bart Vanhaesebroeck et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- ERK1/2 MAP kinases: Structure, function, and regulation
- (2012) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Network Analysis of Epidermal Growth Factor Signaling Using Integrated Genomic, Proteomic and Phosphorylation Data
- (2012) Katrina M. Waters et al. PLoS One
- Suppression of EGFR endocytosis by dynamin depletion reveals that EGFR signaling occurs primarily at the plasma membrane
- (2012) L. P. Sousa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Deciphering the retinoblastoma protein phosphorylation code
- (2012) Seth M. Rubin TRENDS IN BIOCHEMICAL SCIENCES
- MAP Kinase Pathways
- (2012) D. K. Morrison Cold Spring Harbor Perspectives in Biology
- Genomic and Biochemical Insights into the Specificity of ETS Transcription Factors
- (2011) Peter C. Hollenhorst et al. Annual Review of Biochemistry
- Epidermal growth factor receptors destined for the nucleus are internalized via a clathrin-dependent pathway
- (2011) Ana Carolina De Angelis Campos et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity
- (2011) Sarat Chandarlapaty et al. CANCER CELL
- EGFR Nuclear Translocation Modulates DNA Repair following Cisplatin and Ionizing Radiation Treatment
- (2011) G. Liccardi et al. CANCER RESEARCH
- Roles of AKT1 and AKT2 in non-small cell lung cancer cell survival, growth, and migration
- (2011) Myoung W. Lee et al. CANCER SCIENCE
- Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung cancer patients harboring epidermal growth factor receptor mutations: A pooled analysis of published reports
- (2011) Takehito Shukuya et al. CANCER SCIENCE
- Total ERK1/2 activity regulates cell proliferation
- (2011) Renaud Lefloch et al. CELL CYCLE
- A GSK-3-mediated transcriptional network maintains repression of immediate early genes in quiescent cells
- (2011) John W. Tullai et al. CELL CYCLE
- Small tyrosine kinase inhibitors interrupt EGFR signaling by interacting with erbB3 and erbB4 in glioblastoma cell lines
- (2011) Estefanía Carrasco-García et al. EXPERIMENTAL CELL RESEARCH
- Epidermal growth factor-stimulated human cervical cancer cell growth is associated with EGFR and cyclin D1 activation, independent of COX-2 expression levels
- (2011) Bhagavathi Narayanan INTERNATIONAL JOURNAL OF ONCOLOGY
- Epithelial to Mesenchymal Transition in an Epidermal Growth Factor Receptor-Mutant Lung Cancer Cell Line with Acquired Resistance to Erlotinib
- (2011) Kenichi Suda et al. Journal of Thoracic Oncology
- EGFR-mediated G1/S transition contributes to the multidrug resistance in breast cancer cells
- (2011) Shu-Jun Chen et al. MOLECULAR BIOLOGY REPORTS
- PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer
- (2011) V Serra et al. ONCOGENE
- A Functional Nuclear Epidermal Growth Factor Receptor, Src and Stat3 Heteromeric Complex in Pancreatic Cancer Cells
- (2011) Soumya Jaganathan et al. PLoS One
- Feedback upregulation of HER3 (ErbB3) expression and activity attenuates antitumor effect of PI3K inhibitors
- (2011) A. Chakrabarty et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- mTOR Kinase Inhibition Causes Feedback-Dependent Biphasic Regulation of AKT Signaling
- (2011) V. S. Rodrik-Outmezguine et al. Cancer Discovery
- COPI-mediated retrograde trafficking from the Golgi to the ER regulates EGFR nuclear transport
- (2010) Ying-Nai Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Autophagy is a therapeutic target in anticancer drug resistance
- (2010) Suning Chen et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- Nuclear EGFR shuttling induced by ionizing radiation is regulated by phosphorylation at residue Thr654
- (2010) Klaus Dittmann et al. FEBS LETTERS
- Oncogenic mutant forms of EGFR: Lessons in signal transduction and targets for cancer therapy
- (2010) Gur Pines et al. FEBS LETTERS
- Mechanism of Phosphorylation-induced Activation of Phospholipase C-γ Isozymes
- (2010) Aurelie Gresset et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Multiple mechanisms collectively regulate clathrin-mediated endocytosis of the epidermal growth factor receptor
- (2010) Lai Kuan Goh et al. JOURNAL OF CELL BIOLOGY
- MUC1 regulates nuclear localization and function of the epidermal growth factor receptor
- (2010) B. G. Bitler et al. JOURNAL OF CELL SCIENCE
- Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer
- (2010) Marc Peeters et al. JOURNAL OF CLINICAL ONCOLOGY
- Luteolin and gefitinib regulation of EGF signaling pathway and cell cycle pathway genes in PC-3 human prostate cancer cells
- (2010) Barry M. Markaverich et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Spatial control of EGF receptor activation by reversible dimerization on living cells
- (2010) Inhee Chung et al. NATURE
- Understanding resistance to EGFR inhibitors—impact on future treatment strategies
- (2010) Deric L. Wheeler et al. Nature Reviews Clinical Oncology
- Nuclear trafficking of the epidermal growth factor receptor family membrane proteins
- (2010) Y-N Wang et al. ONCOGENE
- RNA helicase A is a DNA-binding partner for EGFR-mediated transcriptional activation in the nucleus
- (2010) L. Huo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of EGF-Stimulated EGF Receptor Endocytosis During M Phase
- (2010) Lei Liu et al. TRAFFIC
- Receptor tyrosine kinase transmembrane domains
- (2010) Edwin Li et al. Cell Adhesion & Migration
- Transmembrane helix-helix interactions involved in ErbB receptor signaling
- (2010) Florian Cymer et al. Cell Adhesion & Migration
- The Akt isoforms are present at distinct subcellular locations
- (2009) Stacey A. Santi et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities
- (2009) Helmout Modjtahedi et al. ANTI-CANCER DRUGS
- The roles of phospholipase D in EGFR signaling
- (2009) Chang Sup Lee et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Modeling ERBB receptor-regulated G1/S transition to find novel targets for de novo trastuzumab resistance
- (2009) Özgür Sahin et al. BMC Systems Biology
- DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival
- (2009) Timothy R. Peterson et al. CELL
- Mechanism for Activation of the EGF Receptor Catalytic Domain by the Juxtamembrane Segment
- (2009) Natalia Jura et al. CELL
- Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy
- (2009) E. Martinelli et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Inhibition of PI3K and MEK: It Is All about Combinations and Biomarkers
- (2009) B. N. Rexer et al. CLINICAL CANCER RESEARCH
- Persistent Corneal Epithelial Defect Associated With Erlotinib Treatment
- (2009) Keegan S Johnson et al. CORNEA
- Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer
- (2009) Pierre Laurent-Puig et al. JOURNAL OF CLINICAL ONCOLOGY
- Site-Specific mTOR Phosphorylation Promotes mTORC1-Mediated Signaling and Cell Growth
- (2009) H. A. Acosta-Jaquez et al. MOLECULAR AND CELLULAR BIOLOGY
- The nuts and bolts of AGC protein kinases
- (2009) Laura R. Pearce et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The role of cooperativity with Src in oncogenic transformation mediated by non-small cell lung cancer-associated EGF receptor mutants
- (2009) B M Chung et al. ONCOGENE
- Roles of Phospholipase C Isozymes in Organogenesis and Embryonic Development
- (2009) Yoshikazu Nakamura et al. PHYSIOLOGY
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Differential Effects of EGFR Ligands on Endocytic Sorting of the Receptor
- (2009) Kirstine Roepstorff et al. TRAFFIC
- Clinical Efficacy and Toxicity of Anti-EGFR Therapy in Common Cancers
- (2009) Amir Harandi et al. Journal of Oncology
- The TSC1–TSC2 complex: a molecular switchboard controlling cell growth
- (2008) Jingxiang Huang et al. BIOCHEMICAL JOURNAL
- Phospholipase C 1 Is Required for Metastasis Development and Progression
- (2008) G. Sala et al. CANCER RESEARCH
- Tenets of PTEN Tumor Suppression
- (2008) Leonardo Salmena et al. CELL
- p27Kip1 nuclear localization and cyclin-dependent kinase inhibitory activity are regulated by glycogen synthase kinase-3 in human colon cancer cells
- (2008) Q Wang et al. CELL DEATH AND DIFFERENTIATION
- Combined Inhibition of c-Src and Epidermal Growth Factor Receptor Abrogates Growth and Invasion of Head and Neck Squamous Cell Carcinoma
- (2008) P. Koppikar et al. CLINICAL CANCER RESEARCH
- Characterization of Ser338Phosphorylation for Raf-1 Activation
- (2008) Mengwei Zang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells
- (2008) R.-H. Tao et al. JOURNAL OF CELL SCIENCE
- Structure and Clinical Relevance of the Epidermal Growth Factor Receptor in Human Cancer
- (2008) Amit Kumar et al. JOURNAL OF CLINICAL ONCOLOGY
- KRASMutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab
- (2008) Astrid Lièvre et al. JOURNAL OF CLINICAL ONCOLOGY
- Block copolymer micelles conjugated with anti-EGFR antibody for targeted delivery of anticancer drug
- (2008) Taiho Noh et al. JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
- Immunohistochemical analysis of phosphorylated epidermal growth factor receptor might provide a surrogate marker of EGFR mutation
- (2008) Hideki Endoh et al. LUNG CANCER
- The RSK family of kinases: emerging roles in cellular signalling
- (2008) Rana Anjum et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- How is SOS activated? Let us count the ways
- (2008) Greg M Findlay et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Membrane-dependent signal integration by the Ras activator Son of sevenless
- (2008) Jodi Gureasko et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- EGFR Antagonists in Cancer Treatment
- (2008) Fortunato Ciardiello et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functional selectivity of EGF family peptide growth factors: Implications for cancer
- (2008) Kristy J. Wilson et al. PHARMACOLOGY & THERAPEUTICS
- The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
- (2008) C.-H. Yun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now